Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 2;4:191. [Version 1] doi: 10.12688/wellcomeopenres.15603.1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2019 Hunt M et al.

This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — Comparison of NEJM-2018, Walker-2015 and candidate panel 3 (CP3) on the Prospective dataset for ( a) first-line drugs and ( b) second-line drugs. Counts of susceptible samples are shown on the left, broken down for each tool/panel into those correctly identified as susceptible (in the colour of the tool/panel), those falsely identified as resistant coloured red and no-calls coloured grey. Similarly, resistant samples are shown on the right, with those correctly identified as resistant coloured by the tool/panel, those falsely identified as susceptible in red, and no-calls in grey. Note that second-line drugs were not considered in NEJM-2018. E, ethambutol; H, isoniazid; Z, pyrazinamide; R, rifampicin; Am, amikacin; Cm, capreomycin; Cfx, ciprofloxacin; Km, kanamycin; Mfx, moxifloxacin; Ofx, ofloxacin; S, streptomycin.